Effect of Estrogen on the Activity and Growth of Human Osteoclasts In Vitro

Accepted 8 December 2008.

Summary

Objective

Estrogen deficiency results in postmenopausal osteoporosis by increasing the rate of bone loss. The mechanism responsible for the effects of estrogen on osteoclasts is still unclear.

Materials and Methods

The potential of mononuclear cells from cord blood or bone marrow to differentiate into mature osteoclasts when co-cultured with human osteoblast cells was investigated. The effects of estrogen on osteoclastogenesis and osteoclast activity were also examined.

Results

Macrophage markers CD11b and CD14 were downregulated and vitronectin receptor was upregulated during 28 days' co-culture of mononuclear cells and human osteoblasts. Long-term co-culture resulted in the formation of numerous large tartrate-resistant acid phosphatase-positive multinucleated cells capable of resorption of bone slices. After incubation for 28 days, the addition of 17β-estradiol caused a significant decrease in the expression of vitronectin receptor and tartrate-resistant acid phosphatase-positive multinucleated cells in cultures derived from both bone marrow and cord blood. A significant decrease in bone resorption was also noted in the presence of estrogen.

Conclusion

Estrogen not only suppresses osteoclastogenesis but also inhibits the activity of osteoclasts.

Key Words: bone marrow , cord blood , osteoblast , postmenopausal osteoporosis

No full text is available. To read the body of this article, please view the PDF online.

Article Outline

• Summary

• References

• Copyright

References

1. 1 Hughes DE , Dai A , Tiffee JC , Li HH , Mundy GR , Boyce BF . Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-β . Nat Med . 1996;2:1132–1136 . MEDLINE | CrossRef

2. 2 Mano H , Yuasa T , Kameda T , et al. Mammalian mature osteoclasts as estrogen target cells . Biochem Biophys Res Commun . 1996;223:637–642 . CrossRef

3. 3 Tobias JH , Chambers TJ . The effect of sex hormones on bone resorption by rat osteoclasts . Acta Endocrinol (Copenh) . 1991;124:121–127 . MEDLINE

4. 4 Horowitz MC . Cytokines and estrogen in bone: anti-osteoporotic effects . Science . 1993;260:626–627 . MEDLINE

5. 5 Manolagas SC , Jilka RL . Bone marrow, cytokines, and bone remodeling: emerging insights into the pathophysiology of osteoporosis . N Engl J Med . 1995;332:305–311 . MEDLINE | CrossRef

6. 6 Pacifici R . Estrogen, cytokines, and pathogenesis of post-menopausal osteoporosis . J Bone Miner Res . 1996;8:1043–1051 .

7. 7 Turner RT , Riggs BL , Spelsberg TC . Skeletal effects of estrogen . Endocr Rev . 1994;15:275–300 . CrossRef

8. 8 Roodman GD . Cell biology of the osteoclast . Exp Hematol . 1999;27:1229–1241 . CrossRef

9. 9 Kimble RB , Bain SD , Pacifici R . The functional block of TNF but not of IL-6 prevents bone loss in ovariectomized mice . J Bone Miner Res . 1997;12:935–941 . MEDLINE | CrossRef

10. 10 Cosman F , Lindsay R . Selective estrogen receptor modulators: clinical spectrum . Endocr Rev . 1999;20:418–434 . CrossRef

11. 11 Chen FP , Lee N , Wang KC , Soong YK , Huan KE . Effect of estrogen and 1α,25(OH)2-vitamin D3 on the activity and growth of human primary osteoblast-like cells in vitro . Fertil Steril . 2002;77:1038–1043 . Abstract | Full Text | Full-Text PDF (94 KB) | CrossRef

12. 12 Stanley ER , Guilbert LJ , Tushinski RJ , Bartelmez SH . CSF-1–a mononuclear phagocyte lineage-specific hemopoietic growth factor . J Cell Biochem . 1983;21:151–159 . MEDLINE | CrossRef

13. 13 Takeshita S , Kaji K , Kudo A . Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts . J Bone Miner Res . 2000;15:1477–1488 . MEDLINE | CrossRef

14. 14 Kawamoto S , Ejiri S , Nagaoka E , Ozawa H . Effects of oestrogen deficiency on osteoclastogenesis in the rat periodontium . Arch Oral Biol . 2002;47:67–73 . Abstract | Full Text | Full-Text PDF (258 KB) | CrossRef

15. 15 Ramalho AC, Couttet P, Baudoin C, Morieux C, Graulet AM, de Vernejoul MC, et al. Estradiol and raloxifene decrease the formation of multinucleate cells in human bone marrow cultures . Eur Cytokine Netw . 2002;13:39–45 . MEDLINE

16. 16 Shevde NK , Bendixen AC , Dienger KM , Pike JW . Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression . Proc Natl Acad Sci U S A . 2000;14:7829–7834 .

17. 17 Srivastava S , Toraldo G , Weitzmann MN , Cenci S , Ross FP , Pacifici R . Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-κB ligand (RANKL)-induced JNK activation . J Biol Chem . 2001;276:8836–8840 . MEDLINE | CrossRef

18. 18 Sarma U , Edwards M , Motoyoshi K , Flanagan AM . Inhibition of bone resorption by 17β-estradiol in human bone marrow cultures . J Cell Physiol . 1998;175:99–108 . MEDLINE | CrossRef

a Department Orthopedic Surgery, Keelung Chang Gung Memorial Hospital and Chang Gung University, College of Medicine, National Taiwan Ocean University, Keelung, Taiwan

b Institute of Marine Biology, National Taiwan Ocean University, Keelung, Taiwan

c Department of Obstetrics and Gynecology, National Taiwan Ocean University, Keelung, Taiwan

Correspondence to: Dr Fang-Ping Chen, Department Of Obstetrics and Gynecology, Keelung Chang Gung Memorial Hospital, 222, Mai-Chin Road, Keelung, Taiwan

PII: S1028-4559(09)60323-5

doi:10.1016/S1028-4559(09)60323-5

4 of 30